Format
Sort by
Items per page

Send to

Choose Destination

Best matches for irritable bowel Campylobacter jejuni:

Search results

Items: 1 to 20 of 44

1.

Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome.

Cao YN, Feng LJ, Liu YY, Jiang K, Zhang MJ, Gu YX, Wang BM, Gao J, Wang ZL, Wang YM.

World J Gastroenterol. 2018 Jan 21;24(3):338-350. doi: 10.3748/wjg.v24.i3.338.

2.

Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.

Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M, Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD.

Mucosal Immunol. 2018 Mar;11(2):474-485. doi: 10.1038/mi.2017.66. Epub 2017 Aug 2. Erratum in: Mucosal Immunol. 2017 Nov 01;:.

PMID:
28766554
3.

Diagnostics: Filling in the missing pieces.

Katsnelson A.

Nature. 2016 May 19;533(7603):S110-1. doi: 10.1038/533S110a. No abstract available.

PMID:
27191489
4.

Status of vaccine research and development for Campylobacter jejuni.

Riddle MS, Guerry P.

Vaccine. 2016 Jun 3;34(26):2903-2906. doi: 10.1016/j.vaccine.2016.02.080. Epub 2016 Mar 11. Review.

5.

Campylobacter jejuni increases flagellar expression and adhesion of noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and CXCL-8 expression.

Reti KL, Tymensen LD, Davis SP, Amrein MW, Buret AG.

Infect Immun. 2015 Dec;83(12):4571-81. doi: 10.1128/IAI.00970-15. Epub 2015 Sep 14.

6.

Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis.

Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, Garcia-Perez JE, Van Oudenhove L, Van Ranst M, Verhaegen J, Liston A, Boeckxstaens G.

Gut. 2016 Aug;65(8):1279-88. doi: 10.1136/gutjnl-2015-309460. Epub 2015 Jun 12.

PMID:
26071133
7.

Claudin-related intestinal diseases.

Barmeyer C, Schulzke JD, Fromm M.

Semin Cell Dev Biol. 2015 Jun;42:30-8. doi: 10.1016/j.semcdb.2015.05.006. Epub 2015 May 19. Review.

PMID:
25999319
8.

Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.

Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, Chua KS, Srinivasan S, Barlow GM, Chang C.

Dig Dis Sci. 2015 May;60(5):1195-205. doi: 10.1007/s10620-014-3435-5. Epub 2014 Nov 26.

PMID:
25424202
9.

Systematic review with meta-analysis: post-infectious functional dyspepsia.

Futagami S, Itoh T, Sakamoto C.

Aliment Pharmacol Ther. 2015 Jan;41(2):177-88. doi: 10.1111/apt.13006. Epub 2014 Oct 27. Review.

10.

Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection.

Nielsen HL, Engberg J, Ejlertsen T, Nielsen H.

Scand J Gastroenterol. 2014 May;49(5):545-51. doi: 10.3109/00365521.2014.886718. Epub 2014 Mar 19.

PMID:
24646319
11.

Role of gut pathogens in development of irritable bowel syndrome.

Grover M.

Indian J Med Res. 2014 Jan;139(1):11-8. Review.

12.

On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens.

Grover M, Camilleri M, Smith K, Linden DR, Farrugia G.

Neurogastroenterol Motil. 2014 Feb;26(2):156-67. doi: 10.1111/nmo.12304. Review.

PMID:
24438587
13.

Preventing Campylobacter at the source: why is it so difficult?

Wagenaar JA, French NP, Havelaar AH.

Clin Infect Dis. 2013 Dec;57(11):1600-6. doi: 10.1093/cid/cit555. Epub 2013 Sep 6.

PMID:
24014733
14.

Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes.

Sung J, Morales W, Kim G, Pokkunuri V, Weitsman S, Rooks E, Marsh Z, Barlow GM, Chang C, Pimentel M.

Neurogastroenterol Motil. 2013 Jun;25(6):529-37. doi: 10.1111/nmo.12118. Epub 2013 Mar 22.

PMID:
23521493
15.

Resistance mechanisms in Campylobacter jejuni.

Iovine NM.

Virulence. 2013 Apr 1;4(3):230-40. doi: 10.4161/viru.23753. Epub 2013 Feb 13. Review.

16.

Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome.

Pokkunuri V, Pimentel M, Morales W, Jee SR, Alpern J, Weitsman S, Marsh Z, Low K, Hwang L, Khoshini R, Barlow GM, Wang H, Chang C.

J Neurogastroenterol Motil. 2012 Oct;18(4):434-42. doi: 10.5056/jnm.2012.18.4.434. Epub 2012 Oct 9.

17.

Campylobacter polysaccharide capsules: virulence and vaccines.

Guerry P, Poly F, Riddle M, Maue AC, Chen YH, Monteiro MA.

Front Cell Infect Microbiol. 2012 Feb 15;2:7. doi: 10.3389/fcimb.2012.00007. eCollection 2012. Review.

18.

Short-term and medium-term clinical outcomes of Campylobacter concisus infection.

Nielsen HL, Engberg J, Ejlertsen T, Bücker R, Nielsen H.

Clin Microbiol Infect. 2012 Nov;18(11):E459-65. doi: 10.1111/j.1469-0691.2012.03990.x. Epub 2012 Aug 7.

19.

Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.

Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG, Neal KR, Whorwell PJ, Hall IP, Spiller RC.

Gut. 2013 Jul;62(7):985-94. doi: 10.1136/gutjnl-2011-301213. Epub 2012 Jun 8.

PMID:
22684480
20.

Risk and prognosis of campylobacteriosis in relation to polymorphisms of host inflammatory cytokine genes.

Nielsen H, Steffensen R, Ejlertsen T.

Scand J Immunol. 2012 Apr;75(4):449-54. doi: 10.1111/j.1365-3083.2012.02678.x.

Supplemental Content

Loading ...
Support Center